Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Platelet-rich plasma therapy shows promise for improving endometrial thickness and implantation rates in IVF for patients with a thin uterine lining, with studies reporting increases of 1 to 3 mm and implantation rates up to 25 to 30 percent compared to 10 to 15 percent without PRP. While generally safe because it uses your own blood, PRP remains experimental and may carry risks such as infection, mild cramping, and unknown long-term effects.
There are several important factors to consider before proceeding including patient candidacy, PRP preparation protocols, timing, and cost, so see below for complete details to guide your next steps.
In vitro fertilization (IVF) offers hope to many couples struggling with infertility. A key step in this process is embryo implantation, where a healthy embryo attaches to the uterine lining (endometrium). Some patients, however, face challenges when their uterine lining is too thin, reducing the chances of successful implantation. Recently, platelet-rich plasma (PRP) has emerged as a potential therapy for improving endometrial thickness and receptivity. This article explores the evidence, benefits, risks, and practical considerations of using PRP for thin uterine lining in IVF cycles.
Platelet-rich plasma (PRP) is a concentration of platelets derived from a patient's own blood. Platelets contain growth factors and cytokines that promote tissue repair and regeneration.
Key components of PRP:
Proposed actions in the uterus:
A healthy endometrial lining typically measures between 7 mm and 14 mm on ultrasound at the time of embryo transfer. When the lining is under 7 mm, studies suggest lower implantation and pregnancy rates.
Reasons for thin lining include:
Several small clinical studies and case reports have explored PRP for thin uterine lining:
Limitations of current research:
While PRP is generally considered safe, it's important to discuss potential downsides:
Clinics vary in timing—some administer PRP during the estrogen phase of the cycle, others right before embryo transfer. Discuss protocol specifics with your fertility specialist.
PRP for thin uterine lining may be considered if you:
While early studies are encouraging, PRP for thin uterine lining remains an emerging therapy. Success is not guaranteed, and outcomes vary widely among individuals. Combining PRP with proven IVF strategies—optimal embryo selection, hormonal support, and lifestyle measures—gives you the best chance of success.
If you're experiencing concerning symptoms like irregular bleeding, pelvic pain, or other reproductive health issues, you can get personalized guidance by using a Medically approved LLM Symptom Checker to help prepare for your conversation with your fertility specialist.
Remember, this article is for informational purposes and does not replace professional medical advice. Speak to your fertility specialist or doctor before starting any new treatment. If you experience severe pain, heavy bleeding, fever, or any life-threatening symptoms, seek immediate medical attention.
Speak to a doctor about your situation to determine the best, evidence-based approach for your IVF journey. Your healthcare team can help tailor therapies—PRP or otherwise—to maximize your chances for a healthy pregnancy.
(References)
* Ma S, Wang J, He J, Yang Z, Lin S, Sun C, Huang J. Intrauterine infusion of autologous platelet-rich plasma (PRP) for infertile women with recurrent implantation failure: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022 Jan 27;13:825028. doi: 10.3389/fendo.2022.825028. PMID: 35147986; PMCID: PMC8829562.
* Chen W, Liu J, Wang Z, Guo W, Dong M, Li H, Chen Z, Zhang C, Cui N. Effect of intra-uterine platelet-rich plasma (PRP) on pregnancy outcomes in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis. J Assist Reprod Genet. 2023 Nov;40(11):2575-2591. doi: 10.1007/s10815-023-02941-5. Epub 2023 Sep 29. PMID: 37775510.
* Maleki-Hajiagha P, Razavi M, Rezaei N, Almasi-Hashiani A, Shahbazi M, Ghaedi F, Zayeri F, Zafari Z. Intrauterine infusion of autologous platelet-rich plasma in women undergoing in vitro fertilization/intracytoplasmic sperm injection cycle with thin endometrium: A systematic review and meta-analysis. J Assist Reprod Genet. 2022 Apr;39(4):815-827. doi: 10.1007/s10815-021-02390-y. Epub 2022 Jan 19. PMID: 35058778.
* Xu G, He Z, Xu S, Liu Y, Wang Z, Chen D. Effectiveness of intrauterine administration of platelet-rich plasma in women with recurrent implantation failure: a systematic review and meta-analysis of randomized controlled trials. J Ovarian Res. 2023 Jul 26;16(1):151. doi: 10.1186/s13048-023-01201-8. PMID: 37497262; PMCID: PMC10372337.
* Sfakianoudis K, Simopoulou M, Nitschelm E, Rapani A, Maziotis E, Tsioulou L, Katsoulis K, Koutsilieris M, Pantos K. Platelet-rich plasma in assisted reproductive technologies: A systematic review and meta-analysis. Clin Exp Reprod Med. 2021 Apr;48(2):93-108. doi: 10.5653/cerm.2021.48.2.93. Epub 2021 Apr 6. PMID: 33830847; PMCID: PMC8074906.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.